Arie Mayer
Director/Board Member presso ORAMED PHARMACEUTICALS INC.
Patrimonio netto: 280 711 $ in data 31/03/2024
Profilo
Arie Mayer is currently the Chairman & Managing Director at Sigma-Aldrich Israel Ltd.
since 2010 and an Independent Director at Oramed Pharmaceuticals, Inc. since 2019.
He holds a doctorate degree from Technion-Israel Institute of Technology and an undergraduate degree from The Hebrew University of Jerusalem.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
06/03/2024 | 96 134 ( 0.24% ) | 280 711 $ | 31/03/2024 |
Posizioni attive di Arie Mayer
Società | Posizione | Inizio |
---|---|---|
ORAMED PHARMACEUTICALS INC. | Director/Board Member | 05/12/2019 |
Sigma-Aldrich Israel Ltd.
Sigma-Aldrich Israel Ltd. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Sigma-Aldrich Israel Ltd. is an Israeli pharmaceutical company that manufactures pharmaceutical products. The private company is based in Rehovot, Israel. Arie Mayer has been the CEO of the company since 1995. | Chief Executive Officer | 01/01/2010 |
Formazione di Arie Mayer
Technion-Israel Institute of Technology | Doctorate Degree |
The Hebrew University of Jerusalem | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ORAMED PHARMACEUTICALS INC. | Health Technology |
Aziende private | 1 |
---|---|
Sigma-Aldrich Israel Ltd.
Sigma-Aldrich Israel Ltd. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Sigma-Aldrich Israel Ltd. is an Israeli pharmaceutical company that manufactures pharmaceutical products. The private company is based in Rehovot, Israel. Arie Mayer has been the CEO of the company since 1995. | Health Technology |
- Borsa valori
- Insiders
- Arie Mayer